These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23805200)

  • 21. A Novel SHOC2 Variant in Rasopathy.
    Hannig V; Jeoung M; Jang ER; Phillips JA; Galperin E
    Hum Mutat; 2014 Nov; 35(11):1290-4. PubMed ID: 25137548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complex.
    Kwon JJ; Hajian B; Bian Y; Young LC; Amor AJ; Fuller JR; Fraley CV; Sykes AM; So J; Pan J; Baker L; Lee SJ; Wheeler DB; Mayhew DL; Persky NS; Yang X; Root DE; Barsotti AM; Stamford AW; Perry CK; Burgin A; McCormick F; Lemke CT; Hahn WC; Aguirre AJ
    Nature; 2022 Sep; 609(7926):408-415. PubMed ID: 35831509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ras and calcium signaling pathways converge at Raf1 via the Shoc2 scaffold protein.
    Yoshiki S; Matsunaga-Udagawa R; Aoki K; Kamioka Y; Kiyokawa E; Matsuda M
    Mol Biol Cell; 2010 Mar; 21(6):1088-96. PubMed ID: 20071468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH 3T3 cells.
    Hochholdinger F; Baier G; Nogalo A; Bauer B; Grunicke HH; Uberall F
    Mol Cell Biol; 1999 Dec; 19(12):8052-65. PubMed ID: 10567531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for SHOC2 modulation of RAS signalling.
    Liau NPD; Johnson MC; Izadi S; Gerosa L; Hammel M; Bruning JM; Wendorff TJ; Phung W; Hymowitz SG; Sudhamsu J
    Nature; 2022 Sep; 609(7926):400-407. PubMed ID: 35768504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bradykinin B(2) receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation.
    Adomeit A; Graness A; Gross S; Seedorf K; Wetzker R; Liebmann C
    Mol Cell Biol; 1999 Aug; 19(8):5289-97. PubMed ID: 10409720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal nitric oxide synthase-induced S-nitrosylation of H-Ras inhibits calcium ionophore-mediated extracellular-signal-regulated kinase activity.
    Raines KW; Cao GL; Lee EK; Rosen GM; Shapiro P
    Biochem J; 2006 Jul; 397(2):329-36. PubMed ID: 16569214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation.
    Coffa S; Breitman M; Hanson SM; Callaway K; Kook S; Dalby KN; Gurevich VV
    PLoS One; 2011; 6(12):e28723. PubMed ID: 22174878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts.
    Duca L; Lambert E; Debret R; Rothhut B; Blanchevoye C; Delacoux F; Hornebeck W; Martiny L; Debelle L
    Mol Pharmacol; 2005 Apr; 67(4):1315-24. PubMed ID: 15653554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.
    Sasaki A; Taketomi T; Kato R; Saeki K; Nonami A; Sasaki M; Kuriyama M; Saito N; Shibuya M; Yoshimura A
    Nat Cell Biol; 2003 May; 5(5):427-32. PubMed ID: 12717443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
    Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
    Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal Growth Factor-dependent Activation of the Extracellular Signal-regulated Kinase Pathway by DJ-1 Protein through Its Direct Binding to c-Raf Protein.
    Takahashi-Niki K; Kato-Ose I; Murata H; Maita H; Iguchi-Ariga SMM; Ariga H
    J Biol Chem; 2015 Jul; 290(29):17838-17847. PubMed ID: 26048984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clathrin-dependent pathway leads to KRas signaling on late endosomes en route to lysosomes.
    Lu A; Tebar F; Alvarez-Moya B; López-Alcalá C; Calvo M; Enrich C; Agell N; Nakamura T; Matsuda M; Bachs O
    J Cell Biol; 2009 Mar; 184(6):863-79. PubMed ID: 19289794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dok-4 regulates GDNF-dependent neurite outgrowth through downstream activation of Rap1 and mitogen-activated protein kinase.
    Uchida M; Enomoto A; Fukuda T; Kurokawa K; Maeda K; Kodama Y; Asai N; Hasegawa T; Shimono Y; Jijiwa M; Ichihara M; Murakumo Y; Takahashi M
    J Cell Sci; 2006 Aug; 119(Pt 15):3067-77. PubMed ID: 16820412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erbin inhibits RAF activation by disrupting the sur-8-Ras-Raf complex.
    Dai P; Xiong WC; Mei L
    J Biol Chem; 2006 Jan; 281(2):927-33. PubMed ID: 16301319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of congenital Shoc2 variants induces AKT-dependent feedback activation of the ERK1/2 pathway.
    Wilson P; Abdelmoti L; Gao T; Galperin E
    bioRxiv; 2023 Dec; ():. PubMed ID: 38187642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of congenital Shoc2 variants induces AKT-dependent crosstalk activation of the ERK1/2 pathway.
    Wilson PG; Abdelmoti L; Gao T; Galperin E
    Hum Mol Genet; 2024 Sep; 33(18):1592-1604. PubMed ID: 38881369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.
    Rajalingam K; Wunder C; Brinkmann V; Churin Y; Hekman M; Sievers C; Rapp UR; Rudel T
    Nat Cell Biol; 2005 Aug; 7(8):837-43. PubMed ID: 16041367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers.
    Jones GG; Del Río IB; Sari S; Sekerim A; Young LC; Hartig N; Areso Zubiaur I; El-Bahrawy MA; Hynds RE; Lei W; Molina-Arcas M; Downward J; Rodriguez-Viciana P
    Nat Commun; 2019 Jun; 10(1):2532. PubMed ID: 31182717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.
    Slack DN; Seternes OM; Gabrielsen M; Keyse SM
    J Biol Chem; 2001 May; 276(19):16491-500. PubMed ID: 11278799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.